1. Home
  2. ATYR vs NMS Comparison

ATYR vs NMS Comparison

Compare ATYR & NMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo aTyr Pharma Inc.

ATYR

aTyr Pharma Inc.

HOLD

Current Price

$0.84

Market Cap

83.3M

Sector

Health Care

ML Signal

HOLD

Logo Nuveen Minnesota Quality Municipal Income Fund

NMS

Nuveen Minnesota Quality Municipal Income Fund

HOLD

Current Price

$11.98

Market Cap

73.8M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATYR
NMS
Founded
2005
1993
Country
United States
United States
Employees
59
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Finance Companies
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
83.3M
73.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ATYR
NMS
Price
$0.84
$11.98
Analyst Decision
Hold
Analyst Count
8
0
Target Price
$4.20
N/A
AVG Volume (30 Days)
1.4M
16.5K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
4.11%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$9,628.95
N/A
Revenue Next Year
$156.94
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.64
$11.07
52 Week High
$7.29
$12.25

Technical Indicators

Market Signals
Indicator
ATYR
NMS
Relative Strength Index (RSI) 43.50 33.55
Support Level $0.82 $11.84
Resistance Level $0.85 $12.00
Average True Range (ATR) 0.07 0.08
MACD -0.02 -0.03
Stochastic Oscillator 7.78 47.73

Price Performance

Historical Comparison
ATYR
NMS

About ATYR aTyr Pharma Inc.

aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).

About NMS Nuveen Minnesota Quality Municipal Income Fund

Nuveen Minnesota Quality Municipal Income Fund is a diversified closed-end management investment company. The Fund's primary investment objective is current income exempt from both regular federal income taxes and Minnesota state income taxes and its secondary investment objective is the enhancement of portfolio value.

Share on Social Networks: